# 02 — Critique of the Title and Chosen Research Direction

## 1. Critique of the original title

> "Early Screening and Risk Stratification of Postpartum Depression and Anxiety Using Explainable Ensemble Machine Learning: A Comparative Benchmark"

| Phrase | Problem (evidence in doc 01) |
|---|---|
| "Early" | No timing variable and no follow-up, so it cannot be demonstrated |
| "Screening" | No reference standard (EPDS, PHQ-9, GAD-7 or clinical interview); the target is one survey item |
| "Risk Stratification" | No validated outcome to check risk groups against |
| "Postpartum Depression **and** Anxiety" | No depression label; "anxiety" is a single yes/no item |
| "Ensemble" | Presents ensembling as the contribution; on this data, ensembles do not beat Random Forest (doc 09) |
| "Comparative Benchmark" | Defensible, but alone it is not a contribution of your own |

## 2. Candidate titles

| ID | Title | Fit to data | Own contribution | Complexity for a beginner |
|---|---|---|---|---|
| **T1** | *Interpretable Postpartum Anxiety Symptom Screening Using Confidence-Gated Hybrid Machine Learning* | High | **Yes: a hybrid method plus a coverage measure** | Low (2 base models, 1 rule) |
| T2 | *Reliability of Explainable ML Benchmarks for Postpartum Anxiety Symptom Prediction: A Leakage-Aware Evaluation* | High | Methodological audit only | Medium (many models and analyses) |
| T3 | *Data Quality Before Model Complexity: Duplication and Label Validity in Postpartum Mental-Health Survey ML* | High | Data audit only | Low, but narrower |
| T4 | *Symptom-Level Postpartum Anxiety Screening Support: A Dual-Dataset Study* | Only with a second, EPDS-labelled dataset | High | Higher |
| T5 | Original title | Low | — | — |

## 3. Chosen direction: T1

1. **It gives you a method of your own** that is small enough to explain in one sentence: "the simple model decides when it is sure, the stronger model handles the rest."
2. **It is testable** with two pre-stated hypotheses (non-inferior to RF, better than LR) and one extra measure, coverage: the share of decisions made by the transparent model.
3. **It fits the data.** LR is reliable when confident (0.81 accuracy) and weak near 0.5 (0.61), where RF does better (0.71). The gate exploits exactly this pattern.
4. **It keeps the audit findings** (duplicates, guilt dependence) as robustness checks instead of hiding them.
5. **It is small:** 2 base models, 1 comparator hybrid, 22 notebook tasks.

T2 and T3 are kept as background: their findings appear in the thesis as the data-audit chapter.

## 4. Optional extension (not assumed)

Public Bangladesh postpartum datasets with EPDS/PHQ-9 scores exist on Mendeley Data (`4nznnrk8cg`, n = 800; `nzgnsrgsg5`, n = 766). They have **not** been downloaded or inspected. If one has a validated label and a compatible licence, running CGTH on it would test whether the method generalises, which is the main step towards a stronger journal submission. Caution from Adhikari & Karki (2026): a PHQ-9 feature dominated predictions on that data, so screening scores must not be used as predictors.

## 5. Language rules

- Say **"screening support"** and **"self-reported anxiety item"**, never "diagnosis" or "anxiety disorder".
- Say **"transparent decisions"** for the LR-decided share, not "explained risk".
- State in the abstract that there is no reference standard and the data are cross-sectional.
